Cargando…
N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC
T-cell immunoglobulin domain and mucin domain 4 (TIM-4) is a transmembrane protein that promotes epithelial-mesenchymal transition (EMT), migration and invasion of non-small cell lung cancer (NSCLC) cells. Most transmembrane proteins are modified by N-glycosylation and the importance of protein N-gl...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008408/ https://www.ncbi.nlm.nih.gov/pubmed/35433445 http://dx.doi.org/10.3389/fonc.2022.730530 |
_version_ | 1784687047454228480 |
---|---|
author | Chen, Siyuan Wang, Yuzhen Liu, Wen Liang, Yan Wang, Yingchun Wu, Zhuanchang Xu, Liyun Liang, Xiaohong Ma, Chunhong Gao, Lifen |
author_facet | Chen, Siyuan Wang, Yuzhen Liu, Wen Liang, Yan Wang, Yingchun Wu, Zhuanchang Xu, Liyun Liang, Xiaohong Ma, Chunhong Gao, Lifen |
author_sort | Chen, Siyuan |
collection | PubMed |
description | T-cell immunoglobulin domain and mucin domain 4 (TIM-4) is a transmembrane protein that promotes epithelial-mesenchymal transition (EMT), migration and invasion of non-small cell lung cancer (NSCLC) cells. Most transmembrane proteins are modified by N-glycosylation and the importance of protein N-glycosylation in cancer cell metastasis has been well appreciated. However, whether TIM-4 is modified by N-glycosylation and the role of TIM-4 N-glycosylation in NSCLC remains largely unknown. In the current study, we reported that TIM-4 was extensively N-glycosylated at Asn291. After the removal of N-glycosylation, the stability of TIM-4 protein was decreased and TIM-4 was more susceptible to degradation by ER-localized ubiquitin ligase-mediated ERAD. Thus, the expression of TIM-4 on the cell surface was decreased, which suppressed TIM-4-mediated metastasis in NSCLC. In summary, the present study identifies TIM-4 N-glycosylation and its role in NSCLS migration, which would provide a valuable biomarker for developing drugs targeting N-glycosylation at Asn291 on TIM-4. |
format | Online Article Text |
id | pubmed-9008408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90084082022-04-15 N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC Chen, Siyuan Wang, Yuzhen Liu, Wen Liang, Yan Wang, Yingchun Wu, Zhuanchang Xu, Liyun Liang, Xiaohong Ma, Chunhong Gao, Lifen Front Oncol Oncology T-cell immunoglobulin domain and mucin domain 4 (TIM-4) is a transmembrane protein that promotes epithelial-mesenchymal transition (EMT), migration and invasion of non-small cell lung cancer (NSCLC) cells. Most transmembrane proteins are modified by N-glycosylation and the importance of protein N-glycosylation in cancer cell metastasis has been well appreciated. However, whether TIM-4 is modified by N-glycosylation and the role of TIM-4 N-glycosylation in NSCLC remains largely unknown. In the current study, we reported that TIM-4 was extensively N-glycosylated at Asn291. After the removal of N-glycosylation, the stability of TIM-4 protein was decreased and TIM-4 was more susceptible to degradation by ER-localized ubiquitin ligase-mediated ERAD. Thus, the expression of TIM-4 on the cell surface was decreased, which suppressed TIM-4-mediated metastasis in NSCLC. In summary, the present study identifies TIM-4 N-glycosylation and its role in NSCLS migration, which would provide a valuable biomarker for developing drugs targeting N-glycosylation at Asn291 on TIM-4. Frontiers Media S.A. 2022-03-31 /pmc/articles/PMC9008408/ /pubmed/35433445 http://dx.doi.org/10.3389/fonc.2022.730530 Text en Copyright © 2022 Chen, Wang, Liu, Liang, Wang, Wu, Xu, Liang, Ma and Gao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Chen, Siyuan Wang, Yuzhen Liu, Wen Liang, Yan Wang, Yingchun Wu, Zhuanchang Xu, Liyun Liang, Xiaohong Ma, Chunhong Gao, Lifen N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC |
title | N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC |
title_full | N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC |
title_fullStr | N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC |
title_full_unstemmed | N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC |
title_short | N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC |
title_sort | n-glycosylation at asn291 stabilizes tim-4 and promotes the metastasis of nsclc |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008408/ https://www.ncbi.nlm.nih.gov/pubmed/35433445 http://dx.doi.org/10.3389/fonc.2022.730530 |
work_keys_str_mv | AT chensiyuan nglycosylationatasn291stabilizestim4andpromotesthemetastasisofnsclc AT wangyuzhen nglycosylationatasn291stabilizestim4andpromotesthemetastasisofnsclc AT liuwen nglycosylationatasn291stabilizestim4andpromotesthemetastasisofnsclc AT liangyan nglycosylationatasn291stabilizestim4andpromotesthemetastasisofnsclc AT wangyingchun nglycosylationatasn291stabilizestim4andpromotesthemetastasisofnsclc AT wuzhuanchang nglycosylationatasn291stabilizestim4andpromotesthemetastasisofnsclc AT xuliyun nglycosylationatasn291stabilizestim4andpromotesthemetastasisofnsclc AT liangxiaohong nglycosylationatasn291stabilizestim4andpromotesthemetastasisofnsclc AT machunhong nglycosylationatasn291stabilizestim4andpromotesthemetastasisofnsclc AT gaolifen nglycosylationatasn291stabilizestim4andpromotesthemetastasisofnsclc |